EN 
AR 
BR 
CA 
CZ 
CL 
CN 
DE 
ES 
FR 
GR 
ID 
IE 
IT 
KE 
KO 
MS 
PT 
PL 
RU 
TH 
UK 
VI 
ZA 
ZH 
ZH_TW - Introduction
- Your Account
- Trading Platforms
- Trading Accounts
- Markets
- Pricing
- MT4 & MT5
- Iress
- Trading Tools
- Copy Trading
- Company
- Education
- Traders Hub
- Help
Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.
Edwards Lifesciences Corp (EW) Profile
Market Cap 79.846B USD Sector(s): Healthcare Industry: Medical Devices
Full-Time Employees: 14,900 (2020) Edwards Lifesciences total assets for the quarter ending September 30, 2021, were $8.160B, a 19.99% increase year-over-year.
Edwards Lifesciences Corporation makes and sells products and technologies for structural heart disease, critical care, and surgical monitoring in the United States, Europe, Japan, and other places around the world. It sells heart valve replacement products that don't require a lot of surgery. It also sells heart valve repair and replacement products to treat mitral and tricuspid valve problems. Additionally, the company offers surgical heart valve therapy products, including pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; and a beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors.
Edwards Lifesciences Corp (EW.xnys) News; Critical Care – Edwards plans to drive growth and leadership with innovations in critical care technologies, with the goal of improving care for 20 million patients annually. The company is currently integrating a full range of Smart Recovery technologies on the HemoSphere monitoring platform that will create a unique offering of enhanced recovery tools to further strengthen the company’s leadership in smart monitoring. Furthermore, in 2022, Edwards anticipates the U.S. launch of its Viewfinder network connectivity solution and the initiation of the SMART BP study. Edwards believes the global hemodynamic monitoring market opportunity will reach approximately $2 billion by 2028.
December 20, 2021
IRVINE, Calif., Dec. 20, 2021 /PRNew swire Edwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the use of the Edwards SAPIEN 3 transcatheter valve with the Alterra adaptive present (SAPIEN 3 with Alterra) for patients with severe pulmonary regurgitation.
Related Instruments
Rolls Royce
-1.34%
Price
100.16
Royal Dutch Shell
+0.19%
Price
17.090
SIEMENS Gamesa
+3.78%
Price
28.9.92
Astrazeneca
-1.34%
Price
100.16
6 Reasons to Trade Share
CFDs with FP Markets
An Australian-regulated
forex & CFD broker
Go Long or Short
Increase your ability to profit in all market conditions Leverage options up to 20:1
Direct Market Access (DMA) Execution
Real-time, transparent share prices Control, Functionality and deep liquidity Full Market depth & see your orders in the queue
Advanced Platforms
& Technology
MT4, MT5, Webtrader & Iress with superior client portal
24/5 Multilingual
Customer Support
Award winning support & personal account managers
Global Exposure
Low margins and competitive commission +10,000 products on global stocks across 4 continents
Earn Dividends
On long positions No ownership of physical shares necessary
Access 10,000+ financial instruments Auto open & close positions News & economic calendar Technical indicators & charts Many more tools included
By supplying your email you agree to FP Markets privacy policy and receive future marketing materials from FP Markets. You can unsubscribe at any time.
Charts by TradingView
Share CFD Trading FAQ
What is a Share CFD?
What is a Share CFD?
Shares represent units of ownership within a company. Shares are also known as stocks or equities. Dividend payments are common with some companies, a method of sharing company profits with shareholders. In addition to traditional share dealing, however, traders can access derivatives: trading instruments derived from the movement of an underlying share price.
Individual stock CFDs (contract for differences) fall under the umbrella of derivative products, an effective low-cost trading vehicle. While CFDs do not grant shareholder privileges, active CFD positions may receive a dividend if executed before the ex-dividend date.
What is the difference between CFD and Shares?
What is the difference
between CFD and Shares?
Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.
While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.
What are the most traded share CFDs?
What are the most
traded share CFDs?
Supply and demand are the main two pillars of share price sharping. The economic situation of countries, in addition to geopolitical risks and instability, can undoubtedly affect trade, financial flow, and consequently the share CFDs prices. In such situations the stock market price fluctuations can be excessively strong, creating opportunities for traders to generate returns investing on the foreign exchange but also excessive risks.
Thus, some well-performing companies offer more opportunities to traders due to their stable, smooth, and less volatile share price movement in the markets. Some of the top traded share CFDs represent the trending industries.
Technology companies such as Tesla Inc, Apple, Microsoft, and Facebook are some of the trader’s favorite shares to trade according to Investing.com. While some of the biotech representatives that have entered the top traded list of the global markets are Moderna, Pfizer, and Johnson & Johnson.
What factors should I consider when trading Share CFDs?
What factors should I
consider when trading
Share CFDs?
The main two driving forces of the forex currency market‘s volatility are supply and demand, placing the share CFDs trading amongst the most distinct volatility performers in the markets.
The economic situation of countries and unions, in addition to geopolitical risks and instability, can undoubtedly affect trade, financial flow, and consequently the interest rate of currencies, economies, and companies. In such situations the stock market price fluctuations can be excessively strong, creating opportunities for traders to generate returns investing on the share CFDs.
For instance, the current global pandemic situation has resulted in traders’ interest turning towards pharmaceutical and biotech companies, delivery and transportation as well as streaming and production services.